Eskitis Institute for Cell and Molecular Therapies

Eskitis 2 building, opened April 2008

The Eskitis Institute for Cell and Molecular Therapies investigates novel drug- and cell-based therapies for human diseases in the thematic areas of:

• Cancer
• Infection and immunity
• Neglected diseases
• Neurodegenerative diseases
• Stem cell biology

These themes were chosen on the basis of the Eskitis Institutes existing expertise and facilities, the importance of the therapeutic area and the potential for future discoveries. The Institute works towards the development of new strategies to prevent and treat diseases, with an emphasis on multi-disciplinary research and collaboration within the Institute and with national and international partners.

Located in the Brisbane Innovation Park adjacent to Griffith University's Nathan Campus (Map PDF 740KB), Eskitis is equipped with industry standard equipment and facilities to speed the development of new strategies to prevent and/or treat these diseases.

Collaborating Partners

• Pfizer - Press release: New partnership to unlock nature's cure for infections
  
• AstraZeneca - Press Release: Promising leads pursued in Griffith University, AstraZeneca collaboration
  
• Innate Pharmaceuticals - Press Release: Experts hunt bacteria blockers
  
• Medicines for Malaria Venture - Press Release: Unique malaria project scoops international award
  
• Drugs for Neglected Diseases Initiative